Global Biodegradable Injectable Dermal Filler market Size, Share & Trends Report by Type (Bio-Degradable and Non-Biodegradable), by End-User (Specialty and Dermatology Clinics, Hospitals and Clinics and Others) Forecast (2022-2028)

The global injectable biodegradable dermal filler market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The rise in the geriatric population which is more prone to skin disorders is one of the factors driving the growth of global biodegradable injectable dermal filler market. For instance, according to the data published by WHO in 2021, the share of the population aged 60 years is anticipated to increase from 1 billion in 2020 to 1.4 billion and by 2050 the world’s population of people aged 60 and older is anticipated to double to 2.1 billion. Moreover, the number of persons aged 80 years and older are anticipated to triple between 2020 to 2050 to reach 426 million.

Looking towards the demand for biodegradable injectable dermal fillers, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Silk Medical Aesthetics had announced the 44-patient feasibility study under FDA-approved clinical trials of About Face by Nature dermal filler. About Face by Nature is a natural dermal filler designed to treat nasolabial folds (NLF). According to Silk Medical Aesthetics, About my face is designed to be biodegradable and reversible for soft tissue augmentation. Moreover, the 13-week clinical results have demonstrated the filler as a safe profile with high patient satisfaction and clinical improvement in NLF severity.

Further, in May 2020, Galderma Laboratories had received the USFDA approval for Restylane Kysse, a hyaluronic acid filler indicated to add fullness to the lips and assist smooth the face wrinkles. According to the company, a lower amount of Restylane Kysse (1.82ml) was needed to show an improvement in the lip fullness as compared to 2.24 ml in the phase 3 trials. Moreover, as per Dr. Melaine Palm (clinical investigator), the Restylane was shown to be safe and well-tolerated. Thus, such launches are anticipated to drive the growth of the biodegradable injectables dermal filler market during the forecast period.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– Galderma Laboratories L.P, Silk Medical Aesthetics Inc and Merz Pharma among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biodegradable Injectable Dermal Filler Market Report by Segment

By Type

• Biodegradable
• Non-Biodegradable

By Application

• Hospitals and Clinics
• Specialty and Dermatological Clinics
• Others

Global Biodegradable Injectable Dermal Fillers Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa